However, information on the changes in circulating CRELD2 levels in ER stress-related diseases, including diabetes, obesity, inflammation, NAFLD, CVDs, kidney diseases, and cancer, is still lacking. This evidence concerns the gene CRELD2 and obesity due to melanocortin 4 receptor deficiency.